Adam Frederik Cohen#
Membership Number: | 6277 |
Membership type: | ORDINARY |
Section: | CLINICAL & VETERINARY SCIENCE |
Elected: | 2022 |
Main Country of Residence: | THE NETHERLANDS |
Homepage(s): | |
ORCID: | 0000-0001-7452-6222 |
Present and Previous Positions
- 2018 - 2021 Research Director Innovation and Consultancy CHDR,Leiden
- 1999 - 2011 Vice chairman and chairman of the Netherlands Central Commission for Medical research (CCMO) and Clinical Trial Competent Authority
- 1993 - 2019 Professor of Clinical Pharmacology, Leiden University Medical Centre
- 2014 - 2019 Board member of Omnicomm Inc (OMCM Nasdaq). Member of audit committee and governance committee
- 1987 - 2018 CEO and sole statutory director Foundation Centre for Human Drug Research Leiden
- 2006 - 2013 CEO of Promasys BV a data management company in Leiden
- 1984 - 1987 European Project leader, Wellcome Research Laboratories, Beckenham, Kent and Research Registrar Department of Nephrology Dulwich Hospital, London, UK
- 1984 Senior house officer, Medicine and Nephrology, Dulwich Hospital, London.
- 1981 - 1984 Department of Clinical Pharmacology,Wellcome Research Laboratories Beckenham, Research physician
- 1980 - 1981 Pre-Registration clinical training
Fields of Scholarship
- Education
- Nephrology and internal medicine
- Clinical drug research
- Methodology for evaluating pharmacological action of medicines in man
- Regulatory and ethical aspects of clinical research
- Organisation of Clinical Research
Honours and Awards
- 2021 DDCD Consultancy. Principal consultant
- 2014 Member of the non-executive board of the Rotterdam Eye Hospital. (2014). Responsible for research and innovation.
- Chairman and founder of the Paul Janssen FutureLab a new school for scientific entrepeneurs established by the Ministry of Health of the Netherlands in association with Leiden University.
- Member of the scientific advisory board of the Netherlands Diabetes Patients Association
- Member of the Scientific Advisory Board of the German Aerospace Research Labs (DLR) Cologne
- Member of the Scientific Advisory Board of FACIO BV (NL)
- Member of the Review Board of the Swiss Nazional Fund (SNF) clinical trials program
- Scientific Advisory Board of the Drug Clinical Trial Center Peking University Third Hospital, Beijing, P.R.China
- Senior Advisor to the Board of the Foundation CHDR Leiden the Netherlands
- Officer in the Royal Order of Orange Nassau
- Fellowship of the Faculty of Pharmaceutical Medicine of the Royal College of Medicine of the UK (FFPM)
- 2009 Fellowship of the American College of Clinical Pharmacology (FCP)
- Fellowship of the British Pharmacological Society (FBPhS)
- Lilly Prize 2017 of the British Pharmacological Society
- 2021 Saal van Zwanenburg prize of the Royal Holland Society for Sciences (KHMVW) for drug development and entrepreneurship